06/10/2022
8:25 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2022
8:20 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2022
8:40 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2022
8:38 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2022
8:36 PM | Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2022
8:35 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2022
8:33 PM | Nektar Therapeutics (Issuer)
NORTHCOTT JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2022
8:32 PM | Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2022
8:09 AM | Nektar Therapeutics (Filer)
| Form DEFA14A
| |
04/29/2022
8:05 AM | Nektar Therapeutics (Filer)
| Form DEF 14A
| |
|
04/25/2022
3:40 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2022
3:44 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2021
5:44 PM | Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2021
5:03 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2021
5:26 PM | GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2021
6:01 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2021
8:47 PM | Nektar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2021
3:21 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2021
6:13 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2021
3:05 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2021
6:08 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2021
6:07 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2021
6:06 PM | Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2021
6:05 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2021
6:04 PM | Nektar Therapeutics (Issuer)
NORTHCOTT JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2021
6:04 PM | Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2021
5:05 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2021
3:21 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2021
11:27 AM | Nektar Therapeutics (Filer)
| Form DEF 14A
| |
04/16/2021
5:02 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
3:21 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2021
6:07 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2021
6:06 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2021
6:05 PM | Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2021
6:04 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2021
6:03 PM | Nektar Therapeutics (Issuer)
NORTHCOTT JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2021
6:03 PM | Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
7:05 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2021
7:44 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2021
7:43 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2021
7:42 PM | Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2021
10:31 AM | Nektar Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/29/2021
5:10 PM | Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2021
6:00 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2021
4:25 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2021
5:06 PM | Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2020
5:53 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2020
5:52 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2020
5:51 PM | Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2020
5:50 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2020
5:49 PM | Nektar Therapeutics (Issuer)
NORTHCOTT JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2020
5:48 PM | Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2020
7:45 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2020
3:31 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2020
5:08 PM | Myriam Curet (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2020
5:09 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2020
6:08 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2020
6:07 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2020
6:05 PM | Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2020
6:04 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2020
6:03 PM | Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2020
7:43 PM | Nektar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2020
3:24 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2020
5:04 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2020
6:03 PM | Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2020
7:16 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2020
7:15 PM | Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
| Form 4/A
| |
09/25/2020
7:14 PM | Lingnau Lutz (Reporting)
Nektar Therapeutics (Issuer)
| Form 4/A
| |
09/25/2020
7:13 PM | GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4/A
| |
09/25/2020
7:13 PM | EASTHAM KARIN (Reporting)
Nektar Therapeutics (Issuer)
| Form 4/A
| |
09/25/2020
7:12 PM | Myriam Curet (Reporting)
Nektar Therapeutics (Issuer)
| Form 4/A
| |
09/25/2020
7:11 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4/A
| |
09/25/2020
7:10 PM | Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
| Form 4/A
| |
09/24/2020
8:40 PM | Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2020
8:39 PM | Lingnau Lutz (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2020
8:38 PM | GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2020
8:38 PM | EASTHAM KARIN (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2020
8:37 PM | Myriam Curet (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2020
8:36 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2020
8:35 PM | Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2020
7:59 PM | Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2020
7:58 PM | Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2020
7:19 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2020
5:18 PM | Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2020
5:41 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2020
5:40 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2020
5:39 PM | Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2020
5:38 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2020
5:37 PM | Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2020
3:10 PM | Nektar Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/06/2020
3:20 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2020
6:06 PM | GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2020
6:05 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
5:33 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
5:32 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
5:31 PM | Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
5:30 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
5:29 PM | Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2020
8:26 PM | Nektar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/17/2020
5:03 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
